Mitigation of the threat posed to transfusion by donors traveling to Zika-affected areas: a Canadian risk-based approach

Transfusion

Volumn 57, Issue 10, 2017, Pages 2463-2468

  Germain, Marc ^a   Delage, Gilles ^a   O'Brien, Sheila F ^b   Grégoire, Yves ^a   Fearon, Margaret ^b   Devine, Dana ^b  

^a HÉMA QUÉBEC   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; CANADIAN; CONTROLLED STUDY; ENDEMIC DISEASE; HEALTH CARE POLICY; HUMAN; INCUBATION TIME; INFECTION RISK; MONTE CARLO METHOD; RISK ASSESSMENT; TRAVEL; VIRUS TRANSMISSION; ZIKA FEVER; CANADA; COMMUNICABLE DISEASE CONTROL; COMPUTER SIMULATION; DONOR SELECTION; ENDEMIC DISEASES; PROCEDURES; TIME FACTOR; TRANSMISSION; ZIKA VIRUS INFECTION;

BLOOD DONORS; BLOOD TRANSFUSION; CANADA; COMMUNICABLE DISEASE CONTROL; COMPUTER SIMULATION; DONOR SELECTION; ENDEMIC DISEASES; HUMANS; RISK ASSESSMENT; TIME FACTORS; TRAVEL; ZIKA VIRUS INFECTION;

EID: 85026475305     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14247     Document Type: Article

References (31)

1. Faria NR, Azevedo RD, Kraemer MU, et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 2016;352:345-9.
2. Brasil P, Pereira JP Jr, Moreira ME, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med 2016;375:2321-34.
3. Honein MA, Dawson AL, Petersen EE, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 2017;317:59-68.
4. Kuehnert MJ, Epstein JS. Assuring blood safety and availability: Zika virus, the latest emerging infectious disease battlefront. Transfusion 2016;56:1669-72.
5. Lanteri MC, Kleinman SH, Glynn SA, et al. Zika virus: a new threat to the safety of the blood supply with worldwide impact and implications. Transfusion 2016;56:1907-14.
6. US Food and Drug Administration. Recommendations for donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika virus. Guidance for industry. Silver Spring (MD): US Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research; 2016 [cited 2017 Jan 10]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM486360.pdf
7. US Food and Drug Administration. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components. Guidance for industry. Silver Spring (MD): US Department of Health and Human Services. Food and Drug Administration. Center for Biologics Evaluation and Research; 2016 [cited 2017 Jan 10]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM518213.pdf
8. Statistics Canada. International travel in 2010 [cited 2017 Jan 10]. Available from: http://www.statcan.gc.ca/pub/66-201-x/2010000/aftertoc-aprestdm1-eng.htm
9. Massad E, Wilder-Smith A. Risk estimates of dengue in travelers to dengue endemic areas using mathematical models. J Travel Med 2009;16:191-3.
10. Pan American Health Organization, World Health Organization. Zika cumulative cases. February 4, 2016 [cited 2017 Jan 10]. Available from: http://www.paho.org/hq/index.php?option=com_content&view=article&id=12390&Itemid=42090&lang=en
11. Burattini MN, Chen M, Chow A, et al. Modelling the control strategies against dengue in Singapore. Epidemiol Infect 2008;136:309-19.
12. Southam CM, Moore AE. Induced virus infections in man by the Egypt isolates of West Nile virus. Am J Trop Med Hyg 1954;3:19-50.
13. Busch MP, Kleinman SH, Tobler LH, et al. Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 2008;198:984-93.
14. Gourinat AC, O'Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M. Detection of Zika virus in urine. Emerg Infect Dis 2015;21:84-6.
15. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14:1232-9.
16. Lazear HM, Diamond MS. Zika virus: new clinical syndromes and its emergence in the western hemisphere. J Virol 2016;90:4864-75.
17. Musso D, Rouault E, Teissier A, et al. Molecular detection of Zika virus in blood and RNA load determination during the French Polynesian outbreak. J Med Virol 2017;89:1505-10.
18. Lessler J, Ott CT, Carcelen AC, et al. Times to key events in Zika virus infection and implications for blood donation: a systematic review. Bull World Health Organ 2016;94:841-9.
19. Bierlaire D, Mauguin S, Broult J, Musso D. Zika virus and blood transfusion: the experience of French Polynesia. Transfusion 2017;57:729-33.
20. Gallian P, Cabié A, Richard P, et al. Zika virus in asymptomatic blood donors in Martinique. Blood 2017;129:263-6.
21. Motta IJ, Spencer BR, Cordeiro da Silva SG, et al. Evidence for transmission of Zika virus by platelet transfusion. N Engl J Med 2016;375:1101-3.
22. Barjas-Castro ML, Angerami RN, Cunha MS, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion 2016;56:1684-8.
23. Murphy MS, Shehata N, Colas JA, et al. Risk of exposure to blood products during pregnancy: guidance for Zika and other donor deferral policies. Transfusion 2017;57(3pt2):811-5.
24. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016;387:1531-9.
25. Mansuy JM, Dutertre M, Mengelle C, et al. Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? Lancet Infect Dis 2016;16:405.
26. Suy A, Sulleiro E, Rodó C, et al. Prolonged Zika virus viremia during pregnancy. N Engl J Med 2016;375:2611-3.
27. Paz-Bailey G, Rosenberg ES, Doyle K, et al. Persistence of Zika virus in body fluids—preliminary report [Epub ahead of print 2017 Feb 14]. N Engl J Med
28. Galel SA, Williamson PC, Busch MP, et al. First Zika-positive donations in the continental United States. Transfusion 2017;57:762-9.
29. US Food and Drug Administration (FDA). Guidance for industry: revised recommendations for reducing the risk of Zika virus transmission by blood and blood components (August 2016). Silver Spring (MD): CBER Office of Communication, Outreach, and Development; 2016.
30. O'Brien SF, Fearon MA, Devine D, Goldman MR, Germain M, Delage G. Estimated risk to the Canadian blood supply from sexually transmitted Zika virus [abstract]. Transfusion 2016;56:12A.
31. Likos A, Griffin I, Bingham AM, et al. Local mosquito-borne transmission of Zika virus—Miami-Dade and Broward counties, Florida, June-August 2016. MMWR 2016;65:1032-8.